Shook Partners Rob Adams, Michael Mallow and Amir Nassihi will be among the presenters for the Current Issues in Pharmaceutical, Medical Device & Biotech Litigation Regional CLE Program, at Pfizer, Inc., in New York City, New York, October 24-25, 2019.
On Tuesday, October 24, Adams will co-present “Jury Selection, Recent Verdicts, and Trends in Individual and Mass Tort Drug/Device Litigation,” and Mallow will moderate “National Class Actions Trends and Caselaw Update.”
The following day, Nassihi will moderate “A View From The Bench: Judicial Perspectives on Managing Complex Litigation,” and Shook alumnus Marc Shelley, global director of litigation at Anheuser-Busch InBev, will be one of the panelists for “Inside View: Legal and Ethical Considerations for In-House Counsel.”
The program is presented by the ABA Section of Litigation Products Liability Committee’s Pharmaceutical, Medical Device & Biotech and Mass Torts Subcommittees, and co-sponsored by the Tort, Trial & Insurance Practice Section. Shook also is a sponsor of the event.
Sessions may be eligible for CLE credit. To learn more or to register for the program, click here to download the brochure.